Sulfamerazine
Lantrisul, Neotrizine, Sulfaloid, Sulfonamides Duplex, Sulfose, Terfonyl, Triple (sulfamerazine) is a small molecule pharmaceutical. Sulfamerazine was first approved as Sulfonamides duplex on 1982-01-01.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Sulfadiazine
+
Sulfamerazine
Sulfamerazine
+
Sulfamethazine)
+
Trisulfapyrimidines (sulfadiazine
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| TERFONYL | Bristol Myers Squibb | N-006904 DISCN | 1982-01-01 | 2 products |
| TRIPLE SULFAS | Lederle Laboratories | N-006920 DISCN | 1982-01-01 | 2 products |
| NEOTRIZINE | Eli Lilly | N-006317 DISCN | 1982-01-01 | 2 products |
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
D: Dermatologicals
— D06: Antibiotics and chemotherapeutics for dermatological use
— D06B: Chemotherapeutics for topical use
— D06BA: Sulfonamides, topical
— D06BA06: Sulfamerazine
J: Antiinfectives for systemic use
— J01: Antibacterials for systemic use
— J01E: Sulfonamides and trimethoprim antibacterials for systemic use
— J01ED: Long-acting sulfonamides
— J01ED07: Sulfamerazine
— J01EE: Combinations of sulfonamides and trimethoprim, incl. derivatives
— J01EE07: Sulfamerazine and trimethoprim
HCPCS
No data
Clinical
No data
Drug
General
| Drug common name | Sulfamerazine |
| INN | sulfamerazine |
| Description | Sulfamerazine is a sulfonamide consisting of pyrimidine with a methyl substituent at the 4-position and a 4-aminobenzenesulfonamido group at the 2-position. It has a role as an antiinfective agent and a drug allergen. It is a member of pyrimidines, a sulfonamide and a sulfonamide antibiotic. It is functionally related to a sulfanilamide. |
| Classification | Small molecule |
| Drug class | antimicrobials (sulfonamides derivatives) |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1 |
Identifiers
| PDB | — |
| CAS-ID | 127-79-7 |
| RxCUI | — |
| ChEMBL ID | CHEMBL438 |
| ChEBI ID | 102130 |
| PubChem CID | 5325 |
| DrugBank | DB01581 |
| UNII ID | UR1SAB295F (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 1,285 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
100 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use